EPISODE · Apr 1, 2022 · 24 MIN
Let's Talk Medtech: Why Embecta Stands Out in Diabetes Care
from Let’s Talk Medtech
Embecta is now fully independent from Becton Dickinson & Co. Devdatt Kurdikar, Embecta's CEO talks about what that means going forward and his plans for the company. With its rich pedigree and newly-independent status, Embecta is truly the new/old kid on the block in diabetes care.
NOW PLAYING
Let's Talk Medtech: Why Embecta Stands Out in Diabetes Care
No transcript for this episode yet
Similar Episodes
Feb 8, 2026 ·4m
Jan 30, 2026 ·6m
Dec 15, 2025 ·2m
Nov 30, 2025 ·5m
Oct 26, 2025 ·14m
Oct 26, 2025 ·61m